Join us at the 2018 European Society for Medical Oncology Congress October 19 - 23 to learn how our NGS-based HTG EdgeSeq chemistry and automation can help shape the future of oncology.
Visit HTG at booth 1008 at the 2018 Annual AMP meeting to learn how our collaborators are innovating next-generation pathology with the NGS-based HTG EdgeSeq system and assays.
Given the inherently complex and dynamic relationship between cancer biology and the immune system, there is great benefit to utilizing high-plex transcriptomic profiling assays to survey broad aspects of biology.
Join HTG for our symposium at ECP on Monday, September 18, 2018 to learn about Next-generation tumor molecular profiling, practical cases.
Meet us in Berlin, Germany at the 102 Jahrestagung der Deutschten Gesellschaft für Pathologie Annual Meeting May 24 - 26 at Estrel Berlin
Meet us in Montpellier, France at the 11th ISMRC Conference May 3 - 5 at The Corum Conference Centre
HTG’s 1:1 Promise Cdx Partnerships, Personalized.
HTG will be at the 2018 ASCO Annual Meeting. Stop by and learn how our NGS-based HTG EdgeSeq chemistry and automation can help shape the future of oncology.
McCormick Place | Chicago, IL | June 1 - June 5 | Booth #4113 | Meeting Room MR1 on Exhibit Hall Floor
Join us Tuesday, May 29, for a webinar with Dr. Richard Myers, Director, Genome Science Institute Boston University School of Medicine.
Open event page and learn more about our customer posters to be presented at this year’s AACR Conference and be sure to stop by booth 4008 for an HTG EdgeSeq instrumentation demo. See you in a few weeks!
Join HTG at the 2018 SFCO Conference and learn more about our NGS-based sequencing assays that are automated on the HTG EdgeSeq system.
Palais Des Congres | Atlantia, FR | March 29 - March 31, 2018
Join HTG at the Molecular Pathology in Oncology at stand 7 and learn more about our HTG EdgeSeq PATH Assay. The assay has been designed for retrospective gene expression profiling to complement traditional immunohistochemistry testing by allowing investigators to assess mRNA expression of large numbers of markers when tissue availability is limited.
Biomedical Research Centre | The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research | London, UK | March 15, 2018
Join us Wednesday, June 28, 2017 at 11:00 am EDT for a Nature Webcast.
Join HTG along with Dr. Omar Mian, Cleveland Clinic, as he discusses the ways advances in therapeutic radiation delivery coupled with improved systemic therapy, including targeted agents and immunotherapy, are revolutionizing the oncology landscape.
Page last updated March 20, 2023